The American Society of Nephrology (ASN) released its first Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases. The guidance, which was published in the Journal of the American Society of Nephrology, provides kidney health professionals and kidney care teams with education on existing tools for obesity management and guidance on implementing those tools within clinical practice based on evidence and expert opinion. ...
Nephrology Times
Nephrology Times delivers the latest news in kidney-related treatments and technologies with the goal of better informing care decisions and improving patient outcomes.
Advertisement
Sponsored Content
Qasim Butt, MD, describes the importance of hyperkalemia management and how LOKELMA can help.
Advertisement
Latest News
The ASN for the first time has issued guidance on the management of obesity in persons with kidney diseases.
A recent study compared anemia diagnosis and treatment in older patients hospitalized in nephrology versus geriatric units.
A proposed HHS rule would remove barriers and increase access to kidney and liver transplantation in the HIV community.
Can GLIM diagnose overnutrition and overnutrition in hemodialysis patients, and how does it compare with SGA?
Kidney care services provider DaVita has named David Maughan as its new chief operating officer.
Researchers developed an updated pediatric prediction tool to determine risk for IgA nephropathy (IgAN) post-biopsy.
Felzartamab was found to be a safe and effective treatment for antibody-mediated rejection in kidney transplantation.
A team studied the effects of remote monitoring on mortality and complications in patients on automated peritoneal dialysis.
Listen to the second part of the discussion of Chapter 15 of Dr. Burton Rose's book, focused on diuretics.
Dr. Michael Aragon of Outset Medical discusses the transition of patients from peritoneal dialysis to home hemodialysis.
Expert Interviews
In Print
American Transplant Congress, 61st ERA Congress, AKI risk prediction, effects of a lifestyle intervention, and more.
NKF Spring Clinical Meetings, ETC payment model, ozone and ESRD risk, IgAN treatments, and more.
Conferences
ATC provides a forum for exchange of new scientific and clinical information relevant to transplantation.
The annual nephrology meeting organized by the European Renal Association
The National Kidney Foundation's premier educational event designed for the interprofessional kidney health team
The annual scientific, educational, and networking meeting of the International Society of Nephrology
Podcasts
Listen to the second part of the discussion of Chapter 15 of Dr. Burton Rose's book, focused on diuretics.
It's time for another NephJC draft! This time the 2024 KDIGO CKD guideline draft is on the clock!
Results of Nefecon (budesonide) for IgA nephropathy set the stage for a glomerulonephritis renaissance.
Vlado Perkovic presented results from the FLOW trial at the 61st ERA Congress, making headlines worldwide.
Expert Columns
The four-pillar approach to treating diabetic kidney disease (DKD) has been endorsed by high-quality trials, such as FLOW.
It is essential for nephrology practices and dialysis centers to have backup methods for processing claims.
IgA nephropathy (IgAN) is on the cusp of a transformational change in its treatment.
Medicare Advantage plans are posing significant operational and financial hurdles for dialysis programs.
APRIL has emerged as a critical factor in the pathogenesis of IgAN and is the focus of several clinical development programs.
The benefit-risk ratio and considerations about unmet need are worth considering.
Knowledge Hubs
Advertisement
Advertisement
Nephrology Times Chair
Ajay K. Singh, MBBS, FRCP, MBASenior Nephrologist, Brigham and Women’s Hospital | Senior Associate Dean, Harvard Medical School
Editorial Board
Mohamed G. Atta, MD, MPHProfessor of Medicine, Johns Hopkins School of Medicine
Timothy E. Bunchman, MDProfessor and Director, Pediatric Nephrology, Transplantation, and Rheumatology, Children’s Hospital of Richmond at VCU
Suphamai Bunnapradist, MD, MSProfessor of Medicine, David Geffen School of Medicine at UCLA | Research Director, Kidney Transplant Program, UCLA
Fernando C. Fervenza, MD, PhDProfessor of Medicine, Division of Nephrology and Hypertension, Mayo Clinic
Kenneth A. Liss, DOPartner, Hypertension and Nephrology Association, Eatontown, NJ
Joel M. Topf, MD, FACPAssistant Clinical Professor of Medicine, Oakland University William Beaumont School of Medicine
